TriSalus Life Sciences (TLSI) Assets Average (2021 - 2026)

TriSalus Life Sciences' Assets Average history runs 6 years deep, the most recent figure standing at $53.2 million for Q1 2026.

• On a quarterly basis, Assets Average rose 102.13% year-over-year to $53.2 million in Q1 2026; TTM through Mar 2026 was $53.2 million, a 102.13% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 22.1% from the prior year.
• Assets Average rose to $53.2 million in Q1 2026 per TLSI's latest filing, from $35.9 million in the prior quarter.
• Across five years, Assets Average topped out at $250.9 million in Q3 2022 and bottomed at $16.4 million in Q2 2023.
• The 5-year median for Assets Average is $30.0 million (2024), against an average of $74.7 million.
• Across the five-year window, Assets Average slumped 93.46% in 2023 and jumped 102.13% in 2026, its largest moves.
• Year by year, Assets Average stood at $136.7 million in 2022, then slumped by 78.72% to $29.1 million in 2023, then declined by 11.53% to $25.7 million in 2024, then jumped by 39.55% to $35.9 million in 2025, then soared by 48.08% to $53.2 million in 2026.
• Per Business Quant, the three latest TLSI Assets Average figures stand at $53.2 million (Q1 2026), $35.9 million (Q4 2025), and $38.9 million (Q3 2025).